Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Mol Neurobiol ; 30(5): 683-92, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20099024

ABSTRACT

In the present work, we have used a rat animal model to study the early effects of intrauterine asphyxia occurring no later than 60 min following the cesarean-delivery procedure. Transitory hypertonia accompanied by altered posture was observed in asphyxiated pups, which also showed appreciably increased lactate values in plasma and hippocampal tissues. Despite this, there was no difference in terms of either cell viability or metabolic activities such as oxidation of lactate, glucose, and glycine in the hippocampus of those fetuses submitted to perinatal asphyxia with respect to normoxic animals. Moreover, a significant decrease in glutamate, but not GABA uptake was observed in the hippocampus of asphyctic pups. Since intense ATP signaling especially through P2X(7) purinergic receptors can lead to excitotoxicity, a feature which initiates neurotransmission failure in experimental paradigms relevant to ischemia, here we assessed the expression level of the P2X(7) receptor in the paradigm of perinatal asphyxia. A three-fold increase in P2X(7) protein was transiently observed in hippocampus immediately following asphyxia. Nevertheless, further studies are needed to delineate whether the P2X(7) receptor subtype is involved in the pathogenesis, contributing to ongoing brain injury after intrapartum asphyxia. In that case, new pharmacologic intervention strategies providing neuroprotection during the reperfusion phase of injury might be identified.


Subject(s)
Asphyxia/pathology , Hippocampus/pathology , Acute Disease , Animals , Animals, Newborn , Asphyxia/blood , Asphyxia/complications , Biological Transport , Cell Survival , Female , Glucose/metabolism , Glutamic Acid/metabolism , Glycine/metabolism , Hippocampus/metabolism , Lactic Acid/blood , Lactic Acid/metabolism , Muscle Hypertonia/blood , Muscle Hypertonia/complications , Muscle Hypertonia/pathology , Phenotype , Pregnancy , Rats , Rats, Wistar , Receptors, Purinergic P2/metabolism , Receptors, Purinergic P2X7
2.
Cell Mol Neurobiol ; 25(5): 913-21, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16133942

ABSTRACT

1. The effect of guanosine on L-[3H] glutamate uptake was investigated in brain cortical slices within physio-pathological range of glutamate(1-1000 microM). In these conditions, glutamate uptake was significantly enhanced in slices treated with 100 microM guanosine only at 100 and 300 microM glutamate (44 and 52%, respectively). 2. Evaluation of kinetic parameters showed that guanosine affected significantly only uptake Vmax (23%). 3. The guanosine withdrawal did not abolish its significant effect on glutamate uptake when 100 or 300 microM glutamate were used (an increase of 66 and 35%, respectively). 4. These results support the hypothesis of a protective role for guanosine during excitotoxic conditions when glutamate levels are enhanced (e.g. brain ischemia and seizures), possibly by activating glutamate uptake. Moreover, our results may contribute to understand the antiexcitotoxic mechanism of guanosine on glutamate transport, giving new information concerning its mechanism of action.


Subject(s)
Cerebral Cortex/metabolism , Glutamic Acid/pharmacokinetics , Guanosine/pharmacology , Animals , Biological Transport/drug effects , Female , Male , Organ Culture Techniques , Rats , Rats, Wistar , Tritium
3.
Neurochem Res ; 29(4): 735-40, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15098935

ABSTRACT

S100B belongs to a family of calcium-binding proteins involved in cell cycle and cytoskeleton regulation. We observed an inhibitory effect of S100B on glial fibrillary acidic protein (GFAP) phosphorylation, when stimulated by cAMP or Ca2+/calmodulin, in a cytoskeletal fraction from primary astrocyte cultures. We found that S100B has no direct effect on CaM KII activity, the major kinase in this cytoskeletal fraction able to phosphorylate GFAP. The inhibition of GFAP phosphorylation is most likely due to the binding of S100B to the phosphorylation sites on this protein and blocking the access of these sites to the protein kinases. This inhibition was dependent on Ca2+. However, Zn2+ could substitute for Ca2+. The inhibitory effect of S100B was prevented by TRTK-12, a peptide that blocks S100B interaction with several target proteins including glial fibrillary acidic protein. These data suggest a role for S100B in the assembly of intermediate filaments in astrocytes.


Subject(s)
Glial Fibrillary Acidic Protein/metabolism , Nerve Growth Factors/physiology , Oligopeptides/pharmacology , S100 Proteins/physiology , Animals , Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , CapZ Actin Capping Protein , Nerve Growth Factors/antagonists & inhibitors , Peptide Fragments , Phosphorylation , Rats , Rats, Wistar , S100 Calcium Binding Protein beta Subunit , S100 Proteins/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...